Mefloquine versus quinine plus sulphalene-pyrimethamine (Metakelfin) for treatment of uncomplicated imported falciparum malaria acquired in Africa

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 2, 2005, Pages 663-667

  Matteelli, Alberto ^a   Saleri, Nuccia ^a   Bisoffi, Zeno ^b   Gregis, Giampietro ^c   Gaiera, Giovanni ^d   Visonà, Raffaella ^e   Tedoldi, Simona ^a   Scolari, Carla ^a   Marocco, Stefania ^b   Gulletta, Maurizio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^c SANT ANNA HOSPITAL   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ARTEMETHER PLUS BENFLUMETOL; ATOVAQUONE PLUS PROGUANIL; BILIRUBIN; CREATININE; LACTATE DEHYDROGENASE; MEFLOQUINE; METAKELFIN; QUININE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MULTICENTER STUDY; NAUSEA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; TINNITUS; TREATMENT OUTCOME; VOMITING;

ADULT; AFRICA; ANTIMALARIALS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIMETHAMINE; QUININE; SULFALENE;

EID: 19944430457     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.2.663-667.2005     Document Type: Article

References (17)

1. Bisoffi, Z., S. Marocco, G. Monteiro, and M. Marsiaj. 1999. Acute intravascular haemolysis (blackwater fever) after antimalarial treatment. Trop. Med. Int. Health 4:72-73.
2. Bousema, J. T., L. C. Gouagna, A. M. Meutstege, B. E. Okech, N. I. Akim, J. I. Githure, J. C. Beier, and R. W. Sauerwein. 2003. Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya. Trop. Med. Int. Health 8:427-430.
3. Castelli, F., A. Matteelli, S. Caligaris, M. Gulletta, I. El-Hamad, C. Scolari, G. Chatel, and G. Carosi. 1999. Malaria in migrants. Parassitologia 41:261-265.
4. Hall, A. P., E. B. Doberstyn, V. Mettaprakong, and P. Sonkom. 1975. Falciparum malaria cured by quinine followed by sulphadoxine-pyrimethamine. Br. Med. J. 2:15-17.
5. Hay, S. I., C. A. Guerra, A. J. Tatem, A. M. Noor, and R. W. Snow. 2004. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect. Dis. 4:327-336.
6. Jelinek, T., C. Schulte, R. Behrens, M. P. Grobusch, J. P. Coulaud, Z. Bisoffi, A. Matteelli, J. Clerinx, M. Corachan, S. Puente, I. Gjorup, G. Harms, H. Kollaritsch, A. Kotlowski, A. Bjorkmann, J. P. Delmont, J. Knobloch, L. N. Nielsen, J. Cuadros, C. Hatz, J. Beran, M. L. Schmid, M. Schulze, R. Lopez-Velez, K. Fleischer, A. Kapaun, P. McWhinney, P. Kern, J. Atougia, G. Fry, S. da Cunha, and G. Boecken. 2002. Imported falciparum malaria in Europe: sentinel surveillance data from the European Network on Surveillance of Imported Infectious Diseases. Clin. Infect. Dis. 34:572-576.
7. Matteelli, A., P. Colombini, M. Gulletta, and F. Castelli for the SIRL Study Group. 1999. Epidemiological features and case management of imported malaria in north western Italy 1991-1995. Trop. Med. Int. Health 4:653-657.
8. Parola, P., S. Ranque, S. Badiaga, M. Niang, O. Blin, J. J. Charbit, J. Delmont, and P. Brouqui. 2001. Controlled trial of 3-day quinine-clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics. Antimicrob. Agents Chemother. 45:932-935.
9. Romi, R., G. Sabatinelli, and G. Majori. 2001. Malaria epidemiological situation in Italy and evaluation of malaria incidence in Italian travelers. J. Travel Med. 8:6-11.
10. Romi, R., D. Boccolini, and G. Majori. 2001. Malaria incidence and mortality in Italy in 1999-2000. Euro. Surveill. 6:143-147.
11. Ronn, A. M., J. Ronne-Rasmussen, P. C. Gotzsche, and I. C. Bygbjerg. 1998. Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study. Trop. Med. Int. Health 3:83-88.
12. Sibley, C. H., J. E. Hyde, P. F. Sims, C. V. Plowe, J. G. Kublin, E. K. Mberu, A. F. Cowman, P. A. Winstanley, W. M. Watkins, and A. M. Nzila. 2001. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17:582-588.
13. Steffen, R. 1991. Travel medicine - prevention based on epidemiological data. Trans. R. Soc. Trop. Med. Hyg. 85:156-162.
14. White, N. J. 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1413-1422.
15. World Health Organization. 1990. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 84(Suppl. 2):S1-S65.
16. World Health Organization. 1996. Management of uncomplicated malaria and the use of antimalarial drugs for the protection of travellers. Report WHO/MAL/96.1075. World Health Organization, Geneva, Switzerland.
17. World Health Organization. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1):S1-S90.